Riskpilot← Back to searchSign inGet full accessAMMEKLINIKKEN AS
ASActiveOrg 916157371Mosterøyveien 517, 4156 MosterøyOther human health activities n.e.c. · NACE 8699Est. 20154 employees
Revenue 2024
NOK 3,7M
-7% vs 2023
EBITDA margin
-2.8%
+80% vs 2023
Equity ratio
44.5%
Financial strength
Net profit 2024
NOK -178K
+64% vs 2023
| Revenue | NOK 3,7M | -7% |
| EBITDA | NOK -103K | +80% |
| Net profit | NOK -178K | +64% |
| Total assets | NOK 2,3M | +41% |
| Equity | NOK 1M | +40% |
| Employees | 4 | — |
Legal name
AMMEKLINIKKEN AS
Org number
916157371
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
30. oktober 2015
Share capital
NOK 55 800
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Ingebjørg kvinge finnesand
Company purpose
Veiledning og hjelp til mødre og barn med ammeproblemer, veiledning i foreldrerollen, import og salg av produkter til forbrukere og foretak, herunder delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Mosterøyveien 517, 4156 Mosterøy
Phone
+4797154669
Email
post@a-mum.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 584 | 3 805 | 3 291 | 3 966 | 3 680 |
| Staff expenses | −622 | −850 | −1 431 | −1 018 | −808 |
| EBITDA | −153 | 304 | −833 | −520 | −103 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −153 | 304 | −833 | −520 | −103 |
| Net financials | 2 | −52 | −72 | −107 | −125 |
| Profit before tax | −151 | 252 | −905 | −627 | −228 |
| Tax | −33 | 57 | −198 | −137 | −50 |
| Net profit | −118 | 195 | −707 | −490 | −178 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 535 | 858 | 1 538 | 1 617 | 2 273 |
| Equity | −1 | 194 | 347 | 725 | 1 012 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 536 | 663 | 1 191 | 892 | 1 261 |
| Total debt | 536 | 663 | 1 191 | 892 | 1 261 |
EBITDA margin
-2.8%
This company
15.8%
Market median
-118% vs market
20202024
Equity ratio
44.5%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
-17.6%
This company
18.4%
Market median
-196% vs market
20202024
Net profit margin
-4.8%
This company
8.1%
Market median
-159% vs market
20202024
Asset turnover
1.62×
This company
1.12×
Market median
+45% vs market
20202024
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 69.93% | 69.93% | 2022 | |
| Company | 13.99% | 13.99% | 2022 | |
| Company | 13.29% | 13.29% | 2022 | |
| Individual | 2.8% | 2.8% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Infin Holding As
AMMEKLINIKKEN AS Board members of AMMEKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingebjørg Kvinge Finnesand | Chairman | 0 companies |
| Endre Schanche Rettedal | Board of Directors | 0 companies |